Pricing and Reimbursement

Consulting in consideration of different stakeholder groups.

 

Pricing and Reimbursement

The benefit of an innovative pharmaceutical should be founded on scientific evidence so that a successful market introduction can be achieved. Therefore, it is of great importance to have all the information of other pharmaceuticals with an existing market authorization and the new therapeutic option from one source at the right time. HTAs, health economic evaluations, and health services research can be important sources for this kind of information. 

Based on a broad understanding for the different stakeholders in the healthcare industry, and a knowledge of their function, along with insight into current reimbursement regulations, we can advise you on strategic questions regarding the pricing and reimbursement of your products.